Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription

被引:213
作者
Akiri, G
Nahari, D
Finkelstein, Y
Le, SY
Elroy-Stein, O
Levi, BZ [1 ]
机构
[1] Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel
[2] NCI, Lab Expt & Computat Biol, DBS, NIH, Frederick, MD 21702 USA
[3] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel
关键词
vascular endothelial growth factor (VEGF); internal ribosome entry site (IRES); 5 ' untranslated region; translational regulation; angiogenesis;
D O I
10.1038/sj.onc.1202019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular Endothelial Growth Factor (VEGF) is very potent angiogenic agent that has a central role in normal physiological angiogenesis as well as in tumor angiogenesis, VEGF expression is induced by hypoxia and hypoglycemia, and thus was suggested to promote neovascularization during tumor outgrowth, Yet, the molecular mechanism that governs VEGF expression is not fully characterized, VEGF induction is attributed in part to increased levels of transcription and RNA stability, Previously, we demonstrated that the 5' Untranslated Region (5' UTR) of VEGF has an important regulatory role in its expression. VEGF has an exceptionally long 5' UTR (1038 bp) which is highly rich in G+C nucleotides, This suggests that secondary structures in the 5' UTR might be essential for VEGF expression through transcriptional and post-transcriptional control mechanisms, as demonstrated for other growth factors, In this communication, we provide evidence that a computer predicted Internal Ribosome Entry Site (IRES) structure is biologically active and is located at the 3' end of the UTR, In addition, the results demonstrate that an alternative transcriptional initiation site for VEGF exists in the 5' UTR of VEGF, This alternative initiation site is 633 bp downstream of the main transcription start site and the resulting 5' UTR includes mainly the IRES structure. Therefore, our results suggest that VEGF is subjected to regulation at either translational level through a mechanism of ribosome internal initiation and/or transcriptional level through alternative initiation.
引用
收藏
页码:227 / 236
页数:10
相关论文
共 52 条
[1]   REGULATION OF START SITE USAGE IN THE LEADER EXONS OF THE RAT INSULIN-LIKE GROWTH FACTOR-I GENE BY DEVELOPMENT, FASTING, AND DIABETES [J].
ADAMO, ML ;
BENHUR, H ;
ROBERTS, CT ;
LEROITH, D .
MOLECULAR ENDOCRINOLOGY, 1991, 5 (11) :1677-1686
[2]  
Bernstein J, 1997, J BIOL CHEM, V272, P9356
[3]   REPORTER CONSTRUCTS WITH LOW BACKGROUND ACTIVITY UTILIZING THE CAT GENE [J].
BOSHART, M ;
KLUPPEL, M ;
SCHMIDT, A ;
SCHUTZ, G ;
LUCKOW, B .
GENE, 1992, 110 (01) :129-130
[4]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[5]   Interleukin 6 induces the expression of vascular endothelial growth factor [J].
Cohen, T ;
Nahari, D ;
Cerem, LW ;
Neufeld, G ;
Levi, BZ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :736-741
[6]   A NOVEL HUMAN C-SIS MESSENGER-RNA SPECIES IS TRANSCRIBED FROM A PROMOTER IN C-SIS INTRON-1 AND CONTAINS THE CODE FOR AN ALTERNATIVE PDGF B-LIKE PROTEIN [J].
DIRKS, RPH ;
ONNEKINK, C ;
JANSEN, HJ ;
DEJONG, A ;
BLOEMERS, HPJ .
NUCLEIC ACIDS RESEARCH, 1995, 23 (15) :2815-2822
[7]   EFFECTS OF A VARIETY OF CYTOKINES AND INDUCING AGENTS ON VASCULAR-PERMEABILITY FACTOR MESSENGER-RNA LEVELS IN U937 CELLS [J].
DOLECKI, GJ ;
CONNOLLY, DT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 180 (02) :572-578
[8]  
FEN Z, 1991, ONCOGENE, V6, P953
[9]   Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442
[10]   Tissue-specific expression of the bovine aromatase-encoding gene uses multiple transcriptional start sites and alternative first exons [J].
Furbass, R ;
Kalbe, C ;
Vanselow, J .
ENDOCRINOLOGY, 1997, 138 (07) :2813-2819